These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 10977967)

  • 21. Universal access to HIV/AIDS treatment: promise and problems.
    Jaffe HW
    JAMA; 2008 Aug; 300(5):573-5. PubMed ID: 18677030
    [No Abstract]   [Full Text] [Related]  

  • 22. [Global AIDS epidemic: from epidemiology to universal treatment].
    Anglaret X
    Rev Med Interne; 2008 Dec; 29 Suppl 3():S269-73. PubMed ID: 18996627
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of mother-to-child transmission of HIV infection.
    Luzuriaga K; Sullivan JL
    Clin Infect Dis; 2005 Feb; 40(3):466-7. PubMed ID: 15668872
    [No Abstract]   [Full Text] [Related]  

  • 24. Maximizing antiretroviral therapy in developing countries: the dual challenge of efficiency and quality.
    Murray CJ
    JAMA; 2015 Jan; 313(4):359-60. PubMed ID: 25436833
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimizing HIV treatment programs.
    Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
    Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 27. Public health. Global HIV/AIDS policy in transition.
    Bongaarts J; Over M
    Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
    [No Abstract]   [Full Text] [Related]  

  • 28. Saving Africa. Baylor College and Secure the Future program pave the way on the continent.
    Vázquez E
    Posit Aware; 2006; 17(2):28-32, 34. PubMed ID: 16610124
    [No Abstract]   [Full Text] [Related]  

  • 29. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.
    Montaner JS; Hogg R; Wood E; Kerr T; Tyndall M; Levy AR; Harrigan PR
    Lancet; 2006 Aug; 368(9534):531-6. PubMed ID: 16890841
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV: global epidemic hits close to home.
    Torre C
    N J Nurse; 2003 Feb; 33(2):3. PubMed ID: 12674880
    [No Abstract]   [Full Text] [Related]  

  • 31. Balancing effectiveness and access to HIV treatment in the developing world.
    Hill A; Wood E
    AIDS; 2007 Jan; 21(3):361-3. PubMed ID: 17255743
    [No Abstract]   [Full Text] [Related]  

  • 32. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral therapy in South Africa--can we do it?
    Bekker LG; Wood R
    S Afr Med J; 2002 Mar; 92(3):191-3. PubMed ID: 12040936
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
    Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
    Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
    [No Abstract]   [Full Text] [Related]  

  • 35. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

  • 36. Affordable antiretroviral drugs for developing countries: dreams of the magic bullet.
    Razum O; Okoye S
    Trop Med Int Health; 2001 Jun; 6(6):421-2. PubMed ID: 11422954
    [No Abstract]   [Full Text] [Related]  

  • 37. Avoid a different standard of care when applying results of Development of Antiretroviral Therapy in Africa (DART) study.
    Sayana S; Manchanda R; Khanlou H; Saavedra J; Reis P; Weinstein M
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):153-4. PubMed ID: 20035167
    [No Abstract]   [Full Text] [Related]  

  • 38. 3 by 5, but at what cost?
    Holmes W
    Lancet; 2004 Mar; 363(9414):1072-3. PubMed ID: 15065565
    [No Abstract]   [Full Text] [Related]  

  • 39. Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Flanigan TP; Wools-Kaloustain K; Harwell J; Cu-Uvin S; Kimaiyo S; Carter EJ
    Clin Infect Dis; 2007 Dec; 45(11):1499-501. PubMed ID: 17990234
    [No Abstract]   [Full Text] [Related]  

  • 40. Called to account.
    Aldhous P
    Nature; 2004 Jul; 430(6996):133. PubMed ID: 15241382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.